Bibliografia UJ CM




Zapytanie: BLOOD
Liczba odnalezionych rekordów: 115



Przejście do opcji zmiany formatu | Wyświetl/ukryj etykiety | Wersja do druku | | | Nowe wyszukiwanie
1/115
Hubert Wysoglad, Elżbieta Szczepanek, Ositadima Chukwu, Weronika Lebowa, Wiktor Nowak, Tomasz Sacha.
Impact of the Covid-19 Pandemic on Quality of Life of Patients with CML
Blood
2021 : Vol. 138, suppl. 1, abstr.
632.Chronic Myeloid Leukemia: Clinical And Epidemiological5, 2021
p-ISSN: 0006-4971
e-ISSN: 1528-0020

SZZ
SIF
Adres url:
2/115
Jorge Cortes, Jane F. Apperley, Elza Lomaia, Beatriz Moiraghi, Maria Soledad Undurraga, Carolina Pavlovsky, Charles Chuah, Tomasz Sacha, Jeffrey H. Lipton, Charles A. Schiffer, James McCloskey, Andreas Hochhaus, Philippe Rousselot, Gianantonio Rosti, Hugues de Lavallade, Anna Turkina, Christine Rojas, Christopher Arthur, Lori J. Maness, Moshe Talpaz, Michael J. Mauro, Tracey Hall, Vickie Lu, Shouryadeep Srivastava, Michael W. Deininger.
Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia : a randomized, open-label phase 2 clinical trial.
Blood
2021 : Vol. 138, nr 21, s. 2042-2050
Auto korespondencyjny: Jorge Cortes.
p-ISSN: 0006-4971
e-ISSN: 1528-0020

AZ
ORG
AIF
IF: 25.669
Adres url:
Streszczenie w PubMed:
DOI:
3/115
Tomasz Sacha, Elzbieta Szczepanek, Paulina Dumnicka, Joanna Gora-Tybor, Joanna Niesiobedzka-Krezel, Witold Prejzner, Ewa Wasilewska, Janusz Kloczko, Hanna Ciepluch, Wioletta Makowska, Elżbieta Patkowska, Joanna Wasilewska, Grazyna Bober, Malgorzata Kopera, Ryszard Wichary, Renata Kroll-Balcerzak, Tomasz Gromek, Malgorzata Wach, Anna Rudkowska-Kazanowska, Magdalena Swiniarska, Edyta Paczkowska, Ewa Medras, Monika Joks, Marta Oller, Renata Kasza, Aleksandra Kostyra, Justyna Gil, Olga Grzybowska-Izydorczyk.
A Multicenter Prospective Study on Efficacy and Safety of Ponatinib in Patients with Chronic Myeloid Leukemia Resistant or Intolerant to Previous Therapy : A 3-Year Report.
Blood
2020 : Vol. 136, suppl. 1, s. 40-41, abstr.
p-ISSN: 0006-4971

SZZ
SIF
Adres url:
4/115
Constantine S. Tam, Stephen Opat, Shirley D'Sa, Wojciech Jurczak, Hui-Peng Lee, Gavin Cull, Roger G. Owen, Paula Marlton Marlton, Björn E. Wahlin, Ramon Garcia Sanz, Helen McCarthy, Stephen Mulligan, Alessandra Tedeschi, Jorge J. Castillo, Jaroslaw Czyz, Carlos Fernandez de Larrea, David Belada, Edward Libby, Jeffrey Matous, Marina Motta, Tanya Siddiqi, Monica Tani, Marek Trneny, Monique C. Minnema, Christian Buske, Veronique Leblond, Judith Trotman, Wai Y. Chan, Jingjing Schneider, Sunhee Ro, Aileen Cohen, Jane Huang, Meletios Dimopoulos.
A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia : the ASPEN study.
Blood
2020 : Vol. 136, nr 18, s. 2038-2050, il., bibliogr. 39 poz., abstr.
Auto korespondencyjny: Constantine S. Tam.
p-ISSN: 0006-4971

AZ
ORG
AIF
IF: 22.113
Adres url:
Streszczenie w PubMed:
5/115
David J. Straus, Monika Długosz-Danecka, Sergey Alekseev, Arpad Illes, Marco Picardi, Ewa Lech-Maranda, Tatyana Feldman, Piotr Smolewski, Kerry J. Savage, Nancy L. Bartlett, Jan Walewski, Radhakrishnan Ramchandren, Pier Luigi Zinzani, Martin Hutchings, Joseph M. Connors, John Radford, Javier Munoz, Won Seog Kim, Ranjana Advani, Stephen M. Ansell, Anas Younes, Harry Miao, Rachael Liu, Keenan Fenton, Andres Forero-Torres, Andrea Gallamini.
Brentuximab vedotin with chemotherapy for stage III/IV classical Hodgkin lymphoma : 3-year update of the ECHELON-1 study.
Blood
2020 : Vol. 135, nr 10, s. 735-742, il., bibliogr. 19 poz., abstr.
Auto korespondencyjny: David J. Straus.
p-ISSN: 0006-4971

AZ
ORG
AIF
IF: 22.113
Adres url:
6/115
Robert Chiesa, Junfeng Wang, Henric-Jan Blok, Sheree Hazelaar, Benedicte Neven, Despina Moshous, Ansgar S. Schulz, Manfred Hoenig, Fabian Hauck, Amal Al Seraihy, Jolanta Gozdzik, Per T. Ljungman, Caroline Lindemans, Juliana Fernandes, Krzysztof Kalwak, Brigitte Strahm, Urs Schanz, Petr Sedlacek, Karl-Walter Sykora, Serap Aksoylar, Franco Locatelli, Polina Stepensky, Robert Wynn, Su Han Lum, Marco Zecca, Fulvio Porta, Mervi Taskinen, Brenda Gibson, Susanne Matthes, Musa Karakukcu, Mathias Hauri-Hohl, Paul Veys, Andrew R. Gennery, Giovanna Lucchini, Matthias Felber, Michael H. Albert, Dmitry Balashov, Arjan Lankester, Tayfun Gungor, Mary Slatter.
Haematopoietic Cell Transplantation in Chronic Granulomatous Disease : a Study on 712 Children and Adults.
Blood
2020 : Vol. 136, nr 10, s. 1201-1211, il., bibliogr. 31 poz., abstr.
Auto korespondencyjny: Mary Slatter.
p-ISSN: 0006-4971

AZ
ORG
AIF
IF: 22.113
Adres url:
Streszczenie w PubMed:
7/115
Elżbieta Szczepanek, Ositadima Chukwu, Magdalena Kamińska, Hubert Wysoglad, Agnieszka Cenda, Joanna Wacław, Magdalena Zawada, Magdalena Jakobczyk, Tomasz Sacha.
Long-Term Outcomes of Imatinib Real-Life Treatment for Chronic Myeloid Leukemia- a 20-Year Review.
Blood
2020 : Vol. 136, suppl. 1, s. 52-53, abstr.
p-ISSN: 0006-4971

SZZ
SIF
Adres url:
8/115
Thierry Facon, Jae Hoon Lee, Philippe Moreau, Ruben Niesvizky, Meletios Dimopoulos, Roman Hajek, Ludek Pour, Artur Jurczyszyn, Lugui Qiu, Zandra Klippel, Anita Zahlten-Kumeli, Muhtarjan Osman, Bruno Paiva, Jesus San-Miguel.
Carfilzomib or bortezomib with melphalan-prednisone for transplant-ineligible patients with newly diagnosed multiple myeloma.
Blood
2019 : Vol. 133, nr 18, s. 1953-1963, il., bibliogr. 32 poz., abstr.
Auto korespondencyjny: Thierry Facon.
p-ISSN: 0006-4971

AZ
ORG
AIF
IF: 17.794
Adres url:
Streszczenie w PubMed:
9/115
Joanna Cieslik, Sandra Mrozinska, Elzbieta Broniatowska, Anetta Undas.
Altered plasma clot properties increase the risk of recurrent deep vein thrombosis: a cohort study.
Blood
2018 : Vol. 131, nr 7, s. 797-807, il., bibliogr. 41 poz., abstr.
Autor korespondencyjny: Anetta Undas.
p-ISSN: 0006-4971

AZ
ORG
AIF
IF: 16.562
Adres url:
Streszczenie w PubMed:
10/115
Sanne Noort, Martin Zimmermann, Dirk Reinhardt, Wendy Cuccuini, Martina Pigazzi, Jenny Smith, Rhonda E. Ries, Todd A. Alonzo, Betsy Hirsch, Daisuke Tomizawa, Franco Locatelli, Tanja A. Gruber, Susana Raimondi, Edwin Sonneveld, Daniel K. Cheuk, Michael Dworzak, Jan Stary, Jonas Abrahamsson, Nira Arad-Cohen, Malgorzata Czogala, Barbara De Moerloose, Henrik Hasle, Soheil Meshinchi, Marry van den Heuvel-Eibrink, C. Michel Zwaan.
Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group.
Blood
2018 : Vol. 132, nr 15, s. 1548-1592, il., bibliogr. 60 poz., abstr.
Autor korespondencyjny: C. Michel Zwaan.
p-ISSN: 0006-4971

AZ
ORG
AIF
IF: 16.562
Adres url:
Streszczenie w PubMed:
11/115
Marta Libura, Sebastian Giebel, Beata Piatkowska-Jakubas, Marat Pawelczyk, Izabella Florek, Karolina Matiakowska, Bozena Jazwiec, Katarzyna Borg, Iwona Solarska, Magdalena Zawada, Sylwia Czekalska, Jolanta Libura, Malgorzata Jakobczyk, Karolina Karabin, Monika Paluszewska, Malgorzata Calbecka, Justyna Gajkowska-Kulik, Grazyna Gadomska, Marek Kielbinski, Anna Ejduk, Dariusz Kata, Sebastian Grosicki, Agnieszka Wierzbowska, Slawomira Kyrcz-Krzemien, Krzysztof Warzocha, Kazimierz Kuliczkowski, Aleksander Skotnicki, Jerzy Holowiecki, Wieslaw Wiktor Jedrzejczak, Olga Haus.
Cladribine added to daunorubicin-cytarabine induction prolongs survival of FLT3-ITD+ normal karyotype AML patients.
Blood
2016 : Vol. 127, nr 3, s. 360-362, il., bibliogr. 15 poz.
p-ISSN: 0006-4971

LR
AIF
IF: 13.164
Adres url:
Streszczenie w PubMed:
12/115
Joanna Gora-Tybor, Tomasz Sacha, Joanna Waclaw, Joanna Niesiobedzka, Olga Grzybowska-Izydorczyk, Ewa Medras, Izabela Deren-Wagemann, Elzbieta Patkowska, Ilona Seferynska, Krzysztof Lewandowski, Anna Wache, Beata Blajer-Olszewska, Marzena Watek, Krzysztof Warzocha, Krzysztof Jamroziak.
Comorbidity Burden and Use of Concomitant Medications at CML Diagnosis: A Retrospective Analysis of 470 Patients from the Polish Adult Leukemia Group (PALG) Registry.
Blood
2016 : Vol. 128, nr 22, s. 1909.
58th ASH Annual Meeting & Exposition, San Diego, California, 3-5 December 2016.
p-ISSN: 0006-4971

SZZ
SIF
Adres url:
13/115
Wojciech Jurczak, Sundra Ramanathan, Pratyush Giri, Francesco Di Raimondo, Heidi Mocikova, Jill Clancy, Mariajose Lechuga, Michelle Casey, Joseph P. Boni, Agnieszka Giza, Georg Hess.
Comparison of 2 Doses of Intravenous (IV) Temsirolimus (Temsr) in Patients with Relapsed/Refractory Mantle Cell Lymphoma (MCL).
Blood
2016 : Vol. 128, nr 22, s. 1775
58th ASH Annual Meeting & Exposition, San Diego, California, 3-5 December 2016.
p-ISSN: 0006-4971

SZZ
SIF
Adres url:
14/115
Joanna Wącław, Magdalena Zawada, Sylwia Czekalska, Bogdan Ochrem, Tomasz Sacha.
Comparison of ABL1 and Gusb Reference Genes in the qRT-PCR Analysis of Halving Time and Early Molecular Response to TKI Therapy in Patients with Chronic Myeloid Leukemia.
Blood
2016 : Vol. 128, nr 22, s. 5424
58th ASH Annual Meeting & Exposition, San Diego, California, 3-5 December 2016.
p-ISSN: 0006-4971

SZZ
SIF
Adres url:
15/115
Johnny Mahlangu, Kazimierz Kuliczkowski, Faraizah Abdul Karim, Oleksandra Stasyshyn, Marina V. Kosinova, Lynda Mae Lepatan, Aleksander Skotnicki, Lisa N. Boggio, Robert Klamroth, Johannes Oldenburg, Andrzej Hellmann, Elena Santagostino, Ross I. Baker, Kathelijn Fischer, Joan C. Gill, Stephanie P'Ng, Pratima Chowdary, Miguel A. Escobar, Claudia Djambas Khayat, Luminita Rusen, Debra Bensen-Kennedy, Nicole Blackman, Tharin Limsakun, Alex Veldman, Katie St. Ledger, Ingrid Pabinger.
Efficacy and safety of rVIII-SingleChain: results of a phase I/III multicenter clinical trial in severe hemophilia A.
Blood
2016 : Vol. 128, nr 5, s. 630-637, il., bibliogr. 24 poz., abstr.
p-ISSN: 0006-4971

AZ
ORG
AIF
IF: 13.164
Adres url:
Streszczenie w PubMed:
16/115
Heinz Gisslinger, Christoph Klade, Pencho Georgiev, Aleksander Skotnicki, Liana Gercheva-Kyuchukova, Miklos Egyed, Viktor Rossiev, Petr Dulicek, Arpad Illes, Halyna Pylypenko, Liliya Sivcheva, Jiri Mayer, Barbara Grohmann-Izay, Hans Hasselbalch, Robert Kralovics, Jean-Jacques Kiladjian.
Final Results from PROUD-PV a Randomized Controlled Phase 3 Trial Comparing Ropeginterferon Alfa-2b to Hydroxyurea in Polycythemia Vera Patients.
Blood
2016 : Vol. 128, nr 22, s. 475
58th ASH Annual Meeting & Exposition, San Diego, California, 3-5 December 2016.
p-ISSN: 0006-4971

SZZ
SIF
Adres url:
17/115
Ajay K. Gopal, Stephen J. Schuster, Nathan Fowler, Judith Trotman, Georg Hess, Jing-Zhou Hou, Abdulraheem Yacoub, Michael Lill, Peter Martin, Umberto Vitolo, Wojciech Jurczak, James Morton, Dzhelil Osmanov, Gary J. Gartenberg, Jessica Vermeulen, Sriram Balasubramanian, Shean-sheng Wang, Sanjay Deshpande, Gilles A. Salles.
Ibrutinib As Treatment for Chemoimmunotherapy-Resistant Patients with Follicular Lymphoma: First Results from the Open-Label, Multicenter, Phase 2 DAWN Study.
Blood
2016 : Vol. 128, nr 22, s. 1217
58th ASH Annual Meeting & Exposition, San Diego, California, 3-5 December 2016.
p-ISSN: 0006-4971

SZZ
SIF
Adres url:
18/115
Tomasz Sacha, Joanna Gora-Tybor, Monika Szarejko, Grażyna Bober, Olga Grzybowska-Izydorczyk, Joanna Niesiobędzka-Krężel, Marek Dudziński, Ewa Wasilewska, Krzysztof Myśliwiec, Justyna Gil, Michał Gniot, Iwona Pietkun, Ewa Mędraś, Joanna Wącław, Krzysztof Giannopoulos.
Imatinib Generics in Treatment of Chronic Myeloid Leukemia; A Prospective Observation in Large Cohort of Patients from Polish (PALG) Imatinib Generics Registry.
Blood
2016 : Vol. 128, nr 22, s. 629.
58th ASH Annual Meeting & Exposition, San Diego, California, 3-5 December 2016.
p-ISSN: 0006-4971

SZZ
SIF
Adres url:
19/115
Marek Trneny, Thierry Lamy, Jan Walewski, David Belada, Jiri Mayer, John A. Radford, Wojciech Jurczak, Franck Morschhauser, Julia Alexeeva, Simon A. Rule, Boris V. Afanasyev, Kamil Kaplanov, Antoine Thyss, Alexej Kuzmin, Sergey Voloshin, Kazimierz Kuliczkowski, Agnieszka Giza, Noel Milpied, Caterina Stelitano, Reinhard Marks, Lorenz Trumper, Tsvetan Biyukov, Evelyn Barnett, Marie-Laure Casadebaig Bravo, Luca Arcaini.
Outcomes Following Lenalidomide for Relapsed/Refractory Mantle Cell Lymphoma Patients at Risk of Bleeding Events Because of Multiple Comorbidities or Treatment: A Post-Hoc Subgroup Analysis of the SPRINT (MCL-002) Trial.
Blood
2016 : Vol. 128, nr 22, s. 2978
58th ASH Annual Meeting & Exposition, San Diego, California, 3-5 December 2016.
p-ISSN: 0006-4971

SZZ
SIF
Adres url:
20/115
Peter Martin, Kami Maddocks, John P. Leonard, Jia Ruan, Andre Goy, Nina Wagner-Johnston, Simon Rule, Ranjana Advani, David Iberri, Tycel Phillips, Stephen Spurgeon, Eliana Kozin, Katherine Noto, Zhengming Chen, Wojciech Jurczak, Rebecca Auer, Ewa Chmielowska, Stephan Stilgenbauer, Johannes Bloehdorn, Craig Portell, Michael E. Williams, Martin Dreyling, Paul M. Barr, Selina Chen-Kiang, Maurizio DiLiberto, Richard R. Furman, Kristie A. Blum.
Postibrutinib outcomes in patients with mantle cell lymphoma.
Blood
2016 : Vol. 127, nr 12, s. 1559-1563, il., bibliogr. 14 poz., abstr.
p-ISSN: 0006-4971

AZ
ORG
AIF
IF: 13.164
Adres url:
Streszczenie w PubMed:
21/115
Qifang Zhang, Dewan Md S. Hossain, Priyanka Duttagupta, Dayson Moreira, Xingli Zhao, Haejung Won, Ralf Buettner, Sergey Nechaev, Marcin Majka, Bin Zhang, Qi Cai, Piotr Swiderski, Ya-Huei Kuo, Stephen Forman, Guido Marcucci, Marcin Kortylewski.
Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia.
Blood
2016 : Vol. 127, nr 13, s. 1687-1700, il., bibliogr. 65 poz., abstr.
p-ISSN: 0006-4971

AZ
ORG
AIF
IF: 13.164
Adres url:
Streszczenie w PubMed:
22/115
Wojciech Jurczak, Pier Luigi Zinzani, Gianluca Gaidano, Andre Goy, Mariano Provencio, Zsolt Nagy, Tadeusz Robak, Kami J. Maddocks, Christian Buske, Sumeet Ambarkhane, Mark Winderlich, Maren Dirnberger-Hertweck, Jan Endell, Kristie A. Blum.
Single-Agent MOR208 in Relapsed or Refractory (R-R) Non-Hodgkin's Lymphoma (NHL): Results from Diffuse Large B-Cell Lymphoma (DLBCL) and Indolent NHL Subgroups of a Phase IIa Study.
Blood
2016 : Vol. 128, nr 22, s. 623
58th ASH Annual Meeting & Exposition, San Diego, California, 3-5 December 2016.
p-ISSN: 0006-4971

SZZ
SIF
Adres url:
23/115
Timothy P. Hughes, Carla Maria Boquimpani, Naoto Takahashi, Noam Benyamini, Nelma Cristina D. Clementino, Vasily Shuvaev, Sikander Ailawadhi, Jeffrey H. Lipton, Anna G. Turkina, Elena Beatriz Moiraghi, Franck E. Nicolini, Jolanta Dengler, Tomasz Sacha, Dong-Wook Kim, Rafik Fellague-Chebra, Sandip Acharya, Nancy Krunic, Yu Jin, François-Xavier Mahon.
Treatment-Free Remission in Patients with Chronic Myeloid Leukemia in Chronic Phase According to Reasons for Switching from Imatinib to Nilotinib: Subgroup Analysis from ENESTop.
Blood
2016 : Vol. 128, nr 22, s. 792.
58th ASH Annual Meeting & Exposition, San Diego, California, 3-5 December 2016.
p-ISSN: 0006-4971

SZZ
SIF
Adres url:
24/115
Yuhuan Wang, Vincent Hayes, Danuta Jarocha, Xiuli Sim, Dawn C. Harper, Rudy Fuentes, Spencer K. Sullivan, Paul Gadue, Stella T. Chou, Beverly J. Torok-Storb, Michael S. Marks, Deborah L. French, Mortimer Poncz.
Comparative analysis of human ex vivo-generated platelets vs megakaryocyte-generated platelets in mice: a cautionary tale.
Blood
2015 : Vol. 125, nr 23, s. 3627-3636, il., bibliogr. 55 poz.
Copyright 2015 by The American Society of Hematology.
p-ISSN: 0006-4971

AZ
ORG
AIF
IF: 11.847
Adres url:
Streszczenie w PubMed:
25/115
Jan Styczynski, Beata Kurylo-Rafinska, Malgorzata Kubicka, Beata Kolodziej, Monika Pogorzala, Krzysztof Czyzewski, Robert Debski, Magdalena Wisniewska, Mariusz Wysocki, Michal Matysiak, Iwona Malinowska, Walentyna Balwierz, Edyta Juraszewska, Jacek Wachowiak, Benigna Konatkowska, Mariola Woszczyk, Igor Olejnik, Maryna Krawczuk-Rybak, Marta Kuzmicz, Jerzy Kowalczyk, Maria Jolanta Stefaniak, Wanda Badowska, Tomasz Szczepanski, Renata Tomaszewska, Elzbieta Adamkiewicz-Drozynska, Lucyna Maciejka-Kemblowska, Grazyna Sobol, Agnieszka Mizia-Malarz, Joanna Szczepanek.
Differential in Vitro Drug Resistance Profile Between First and Second Relapsed Acute Lymphoblastic Leukemia and Acute Myeloblastic Leukemia in Children.
Blood
2015 : Vol. 126, nr 23
57th Annual Meeting of the American-Society-of-Hematology, Orlando, FL, DEC 05-08, 2015.
p-ISSN: 0006-4971

SZZ
SIF
26/115
Michael L. Wang, Kristie A. Blum, Peter Martin, Andre Goy, Rebecca Auer, Brad S. Kahl, Wojciech Jurczak, Ranjana H. Advani, Jorge E. Romaguera, Michael E. Williams, Jacqueline C. Barrientos, Ewa Chmielowska, John Radford, Stephan Stilgenbauer, Martin Dreyling, Wieslaw Wiktor Jedrzejczak, Peter Johnson, Stephen E. Spurgeon, Liang Zhang, Linda Baher, Mei Cheng, Dana Lee, Darrin M. Beaupre, Simon Rule.
Long-term follow-up of MCL patients treated with single-agent ibrutinib: Updated safety and efficacy results.
Blood
2015 : Vol. 126, nr 6, s. 739-745, il., bibliogr. 14 poz., abstr.
p-ISSN: 0006-4971

AZ
ORG
AIF
IF: 11.847
Adres url:
Streszczenie w PubMed:
27/115
Shaji K. Kumar, Jae Hoon Lee, Meletios A. Dimopoulos, Evangelos Terpos, Efstathios Kastritis, Wee Joo Chng, Artur J. Jurczyszyn, Hiroshi Handa, Shuji Ozaki, Xavier Leleu, Philippe Moreau, Juan José Lahuerta, Chaim Shustik, Daniel Dirck Waller, Meral Beksac, Ravi Vij, Kihyun Kim, Jin Seok Kim, Ashraf Z. Badros, Melissa Alsina, Brian G.M. Durie.
Outcomes after Initial Relapse of Multiple Myeloma: An International Myeloma Working Group Study.
Blood
2015 : Vol. 126, nr 23, abstr. 4201
57th Annual Meeting of the American-Society-of-Hematology, Orlando, FL, DEC 05-08, 2015.
p-ISSN: 0006-4971

SZZ
SIF
Adres url:
28/115
Jolanta Skalska-Sadowska, Anna Pieczonka, Katarzyna Smalisz-Skrzypczyk, Michal Matysiak, Katarzyna Muszynska-Roslan, Maryna Krawczuk-Rybak, Katarzyna Drabko, Jerzy Kowalczyk, Malgorzata Czogala, Walentyna Balwierz, Grazyna Karolczyk, Irena Karpinska-Derda, Mariola Woszczyk, Tomasz Szczepanski, Jacek Wachowiak.
Unsatisfactory Outcome of Pediatric Relapsed and Refractory AML Treated with Clofarabine Combined with Topotecan, Vinorelbine and Thiotepa (TVTC).
Blood
2015 : Vol. 126, nr 23
57th Annual Meeting of the American-Society-of-Hematology, Orlando, FL, DEC 05-08, 2015.
p-ISSN: 0006-4971

SZZ
SIF
29/115
Kim Klein, Gertjan Kaspers, Christine J. Harrison, Berna Beverloo, Ardine Reedijk, Mathilda Bongers, Jacqueline Cloos, Andrea Pession, Dirk Reinhardt, Martin Zimmermann, Ursula Creutzig, Michael Dworzak, Todd A. Alonzo, Donna Johnston, Michal Zapotocky, Barbara De Moerloose, Alcira Fynn, Vincent Lee, Takashi Taga, Akio Tawa, Anne Auvrignon, Bernward Zeller, Carmen Salgado, Walentyna Balwierz, Alexander Popa, Jeffrey E. Rubnitz, Brenda Gibson.
Clinical Impact of Additional Cytogenetic Aberrations, cKIT- and RAS Mutations and Other Factors in Pediatric t(8;21)-AML.
Blood
2014 : Vol. 124, nr 21
56th Annual Meeting of the American-Society-of-Hematology, San Francisco, CA, DEC 06-09, 2014.
p-ISSN: 0006-4971

SZZ
SIF
30/115
Malgorzata Salamonowicz, Lukasz Hutnik, Michal Matysiak, Joanna Rogulska, Edyta Podsiadly, Urszula Demkow, Zofia Malas, Wanda Badowska, Olga Zajac-Spychala, Jacek Wachowiak, Filip Pierlejewski, Wojciech Mlynarski, Renata Tomaszewska, Tomasz Szczepanski, Tomasz Ociepa, Tomasz Urasinski, Krzysztof Czyzewski, Mariusz Wysocki, Agnieszka Urbanek-Dadela, Grazyna Karolczyk, Zuzanna Gamrot, Maria Wieczorek, Marcin Plonowski, Maryna Krawczuk-Rybak, Weronika Stolpa, Grazyna Sobol-Milejska, Ninela Irga-Jaworska, Elzbieta Drozynska, Liliana Chelmecka-Hanusiewicz, Walentyna Balwierz, Ewa Gorczynska, Krzysztof Kalwak, Jerzy Kowalczyk, Jan Styczynski.
Infectious Complications in Children with ALL Treated with ALL-IC-2009 Protocol: Multicenter National Study of Polish Society of Pediatric Hematology and Oncology.
Blood
2014 : Vol. 124, nr 21
56th Annual Meeting of the American-Society-of-Hematology, San Francisco, CA, DEC 06-09, 2014.
p-ISSN: 0006-4971

SZZ
SIF
31/115
Heinz Gisslinger, Mirjana Gotic, Jerzy Holowiecki, Miroslav Penka, Juergen Thiele, Hans-Michael Kvasnicka, Robert Kralovics, Petro E. Petrides, ANAHYDRET Study Group.
Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial.
Blood
2013 : Vol. 121, nr 10, s. 1720-1728, il., bibliogr. 49 poz.
p-ISSN: 0006-4971

AZ
ORG
AIF
IF: 9.775
32/115
Jorge E. Cortes, Carmino Antonio De Souza, Jose Luis Lopez, Manuel Ayala, Eduardo Bullorsky, Xiaojun Huang, Sandip Shah, K. Govind Babu, Tomasz Sacha, Israel Bendit, Zhizhou Liang, Tina Owugah, Prasanna Kumar Nidamarthy, Tomasz Szczudlo, Carmen Piccolo, Philipp D. le Coutre.
Switching To Nilotinib In Patients (pts) With Chronic Myeloid Leukemia In Chronic Phase (CML-CP) With Suboptimal Cytogenetic Response (CyR) On Imatinib: First Results Of The LASOR Trial.
Blood
2013 : Vol. 122, nr 21, s. 95
55th Annual Meeting and Exposition; New Orleans, Louisiana, USA; December 7-13, 2013.
p-ISSN: 0006-4971

SZZ
SIF
Adres url:
33/115
Mariusz Korkosz, Karolina Bukowska-Strakova, Seth Sadis, Tomasz Grodzicki, Maciej Siedlar.
Monoclonal antibodies against macrophage colony-stimulating factor diminish the number of circulating intermediate and nonclassical (CD14++CD16+/CD14+CD16++) monocytes in rheumatoid arthritis patient.
Blood
2012 : Vol. 119, nr 22, s. 5329-5330, il., bibliogr. 8 poz.
p-ISSN: 0006-4971

LR
AIF
IF: 9.060
34/115
Jan Styczynski, Adriana Balduzzi, Lidia Gil, Myriam Labopin, Rose-Marie Hamladji, Sarah Marktel, M.Akif Yesilipek, Franca Fagioli, Karoline Ehlert, Martina Matulova, Jean-Hugues Dalle, Jacek Wachowiak, Maurizio Miano, Chiara Messina, Miguel Angel Diaz, Christiane Vermylen, Mathias Eyrich, Isabel Badell, Peter Dreger, Jolanta Gozdzik, Daphna Hutt, Jelena Rascon, Giorgio Dini, Christina Peters.
Risk of complications during hematopoietic stem cell collection in pediatric sibling donors: a prospective European Group for Blood and Marrow Transplantation Pediatric Diseases Working Party study.
Blood
2012 : Vol. 119, nr 12, S. 2935-2942, il., bibliogr. 36 poz., abstr.
p-ISSN: 0006-4971

AZ
ORG
AIF
IF: 9.060
35/115
Thomas Ernst, Feng Lin, Helen E. White, Paul La Rosee, Thomas Lion, Gerlinde Mitterbauer-Hohendann, Peter Vandenberghe, Renata Zadro, Katerina Machova Polakova, Radek Plachy, Charlotte Guldborg Nyvold, Tuija Lundan, Jean-Michel Cayuela, Thoralf Lange, Martin C. Muller, Katerina Zoi, Hajnalka Andrikovics, Tali Tohami, Fabrizio Pane, Simona Soverini, Francesca Arruga, Lene Eggen, Tomasz Sacha, Joana Diamond, Rodica Talmaci, Tadej Pajic, Dolors Colomer, Monica Hermanson, Elisabeth Oppliger Leibundgut, Peter J.M. Valk, Ugur Ozbek, Gareth Gerrard, Giuseppe Saglio, Andreas Hochhaus, Nicholas C.P. Cross.
Harmonized testing for BCR-ABL kinase domain mutations in CML : results of a survey and first control round within 28 national reference laboratories in Europe.
Blood
2010 : Vol. 116, nr 21, abstr. 894
52nd ASH Annual Meeting, Orlando, FL, December 4-7, 2010.
SZZ
SIF
36/115
Wojciech Jurczak, Marcin Sobocinski, Jagoda Gorka, Jacek Cieslak, Joanna Drozd-Sokolowska, Piotr Boguradzki, Justyna Dzietczenia, Monika Joks, Andrzej Deptala, Magdalena Halasz, Tomasz Wrobel, Grzegorz Mazur, Aleksander Skotnicki.
High incidence of cardiovascular complications after CHOP-like chemotherapy in lymphoma patients from Poland - retrospective analysis of polish lymphoma research group (PLRG).
Blood
2010 : Vol. 116, nr 21, abstr. 1764
52nd ASH Annual Meeting, Orlando, FL, December 4-7, 2010.
SZZ
SIF
37/115
Sebastian Giebel, Jerzy Holowiecki, Malgorzata Krawczyk-Kulis, Krystyna Jagoda, Jaroslaw Piszcz, Monika Paluszewska, Maria Adamczyk-Cioch, Anna Ejduk, Anna Czyz, Beata Piatkowska-Jakubas, Ewa Lech-Maranda, Beata Stella-Holowiecka, Monika Szarejko, Slawomira Kyrcz-Krzemien, Janusz Kloczko, Wieslaw Wiktor Jedrzejczak, Anna Dmoszynska, Krzysztof Warzocha, Mieczyslaw Komarnicki, Aleksander Skotnicki, Tadeusz Robak, Andrzej Hellmann, Barbara Zdziarska, Kazimierz Sulek, Maria Domagala, Malgorzata Razny, Krystyna M. Zawilska, Jolanta Starzak-Gwozdz.
Improved outcome of adult acute lymphoblastic leukemia treated with individualized protocol adjusted to the status of minimal residual disease and age. Interim analysis of PALG ALL 5-2007 study.
Blood
2010 : Vol. 116, nr 21, abstr. 2138
52nd ASH Annual Meeting, Orlando, FL, December 4-7, 2010.
SZZ
SIF
38/115
Wojciech Jurczak, Justyna Dzietczenia, Beata Piatkowska-Jakubas, Marcin Sobocinski, Tomasz Ogorka, Agnieszka Giza, Grzegorz Mazur, Tomasz Wrobel, Aleksander Skotnicki.
Liposomal cytarabine (DepoCyte) is effective and well tolerated in prophylaxis of central nervous system (CNS) relapse of high risk lymphoma patients.
Blood
2010 : Vol. 116, nr 21, abstr. 4890
52nd ASH Annual Meeting, Orlando, FL, December 4-7, 2010.
SZZ
SIF
39/115
Loems Ziegler-Heitbrock, Petronela Ancuta, Suzanne Crowe, Marc Dalod, Veronika Grau, Derek N. Hart, Pieter J.M. Leenen, Yong-Jun Liu, Gordon MacPherson, Gwendalyn J. Randolph, Juergen Scherberich, Juergen Schmitz, Ken Shortman, Silvano Sozzani, Herbert Strobl, Marek Zembala, Jonathan M. Austyn, Manfred B. Lutz.
Nomenclature of monocytes and dendritic cells in blood.
Blood
2010 : Vol. 116, nr 16, s. e74-80, il., bibliogr. 70 poz.
p-ISSN: 0006-4971

AZ
ORG
AIF
IF: 10.558
40/115
Martin C. Muller, Umang Munjal, Philipp Erben, Thomas Lion, Gerlinde Mitterbauer-Hohendann, Hakim El Housni, Nancy Boeckx, Renata Zadro, Jiri Mayer, Peter Rohon, Jana Rulcova, Lykke Grubach, Kadri Raudsepp, Veli Kairisto, Francois-Xavier Mahon, Claude Preudhomme, Sandrine Hayette, Jean Gabert, Jean-Michel Cayuela, Christian Thiede, Lars Galonska, Heike Pfeifer, Carsten Hirt, Philippe Schafhausen, Nils von Neuhoff, Martin Roskos, Christiane Pott, Thoralf Lange, Georg Hess, Susanne Schnittger, Annika Dufour, Steffen Koschmieder, Frank Stegelmann, Katerina Zoi, Kostas Stamatopoulos, Hajnalka Andrikovics, Tali Tohami, Giovanni Martinelli, Barbara Izzo, Enrico Gottardi, Mindaugas Stoskus, Dag Andre Nymoen, Tomasz Sacha, Joana Diamond, Rodica Talmaci, Andrey Misyurin, Michael V. Dubina, Tadej Pajic, Josep F. Nomdedeu, Dolors Colomer, Gisela Barbany-Bustinza, Hans Ehrencrona, Elisabeth Oppliger Leibundgut, Jeroen Janssen, Vincent H.J. Van der elden, Peter J.M. Valk, Ugur Ozbek, Lihui Wang, Gareth Gerrard, Helen E. White, Thomas Schenk, Thomas Ernst, Rudiger Hehlmann, Giuseppe Saglio, Andreas Hochhaus, Nicholas C.P. Cross.
Stability of conversion factors for BCR-ABL monitoring - implications for the frequency of validation rounds.
Blood
2010 : Vol. 116, nr 21, abstr. 893
52nd ASH Annual Meeting, Orlando, FL, December 4-7, 2010.
SZZ
SIF
41/115
Jean-Luc Harousseau, Giovanni Martinelli, Wieslaw W. Jedrzejczak, Joseph M. Brandwein, Dominique Bordessoule, Tamas Masszi, Gert J. Ossenkoppele, Julia A. Alexeeva, Gernot Beutel, Johan Maertens, Maria-Belen Vidriales, Herve Dombret, Xavier Thomas, Alan K. Burnett, Tadeusz Robak, Nuriet K. Khuageva, Anatoly K. Golenkov, Elena Tothova, Lars Mollgard, Youn C. Park, Annick Bessems, Peter De Porre, Angela J. Howes, FIGHT-AML-301 Investigators.
A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older.
Blood
2009 : Vol. 114, nr 6, s. 1166-1173, il., bibliogr. 27 poz.
AZ
ORG
AIF
IF: 10.555
Adres url:
Streszczenie w PubMed:
DOI:
42/115
Anetta Undas, Krystyna Zawilska, Mariola Ciesla-Dul, Agata Lehmann-Kopydłowska, Agnieszka Skubiszak, Katarzyna Ciepłuch, Wiesława Tracz.
Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives.
Blood
2009 : Vol. 114, nr 19, s. 4272-4278, bibliogr.
p-ISSN: 0006-4971

AZ
ORG
AIF
IF: 10.555
43/115
Jerzy Holowiecki, Sebastian Grosicki, Slawomira Kyrcz-Krzemien, Kazimierz Kuliczkowski, Aleksander B. Skotnicki, Andrzej Hellmann, Tadeusz Robak, Kazimierz Sulek, Anna Dmoszynska, Janusz Kloczko, Wieslaw Wiktor Jedrzejczak, Barbara Zdziarska, Krzysztof Warzocha, Krystyna Maria Zawilska, Sebastian Giebel, Mieczyslaw Komarnicki, Marek Kielbinski, Beata Piatkowska-Jakubas, Agnieszka Wierzbowska, Olga Haus, Beata Stella-Holowiecka, Malgorzata Krawczyk-Kulis, Malgorzata Wach, Tomasz Czerw, Anna Ejduk.
Cladribine in combination with standard Daunorubicine and Cytarabine (DAC) as a remission induction treatment improves the verall survival in untreated adults with AML aged < 60 y contrary to combination including Fludarabine (DAF) : A multicenter, randomized, phase III PALG AML 1/2004 DAC/DAF/DA study in 673 patients-a final update.
Blood
2009 : Vol. 114, nr 22, abstr. 2055
51st ASH Annual Meeting, New Orleans, USA, [5-8 December 2009].
SZZ
SIF
44/115
Wojciech Jurczak, Aleksander B. Skotnicki, Andrzej Deptala, Christine Windemuth-Kieselbach, Michael Lorsbach, Angelika Bischof Delaloye, Suh Cheolwon, Pier Luigi Zinzani, Roberto Cacchione, Werner Linkesch, Francesco d'Amore, Lorenz H. Truemper.
Consolidation with radioimmunotherapy may prolong survival in first remission of mantle cell lymphoma patients uneligible for stem cell transplantation, an analysis of the International RIT-Network.
Blood
2009 : Vol. 114, nr 22, abstr. 3746
51st ASH Annual Meeting, New Orleans, USA, [5-8 December 2009].
SZZ
SIF
45/115
Wojciech Jurczak, Michal Szymczyk, Agnieszka Giza, Monika Joks, Elzbieta Kisiel, Beata Stella-Holowiecka, Piotr Boguradzki, Tomasz Wrobel, Magdalena Sikorska, Wanda Knopinska-Posluszny, Ewa Kalinka-Warzocha, Jan Walewski, Aleksander B. Skotnicki.
Overall survival (OS) benefit of Rituximab based immunochemotherapy followed by post-induction treatment in Mantle Cell Lymphoma (MCL) : a retrospective analysis of 279 patients treated by Polish Lymphoma Research Group (PLRG) Centers.
Blood
2009 : Vol. 114, nr 22, abstr. 1702
51st ASH Annual Meeting, New Orleans, USA, [5-8 December 2009].
SZZ
SIF
46/115
Kajetana Foryciarz, Tomasz Sacha, Izabela Florek, Sylwia Czekalska, Magdalena Zawada, Aleksander B. Skotnicki.
Prognostic factors in treatment of chronic myeloid leukemia with tyrosine kinase inhibitors- single center experience.
Blood
2009 : Vol. 114, nr 22, abstr. 2210
51st ASH Annual Meeting, New Orleans, USA, [5-8 December 2009].
SZZ
SIF
47/115
Sebastian Giebel, Beata Stella-Holowiecka, Malgorzata Krawczyk-Kulis, Nicola Goekbuget, Dieter Hoelzer, Michael Doubek, Jiri Mayer, Beata Piatkowska-Jakubas, Aleksander Skotnicki, Herve Dombret, Joseph-Maria Ribera, Pier Paolo Piccaluga, Tomasz Czerw, Maria Sadus-Wojciechowska, Slawomira Kyrcz-Krzemien, Jerzy Holowiecki.
Status of minimal residual disease determines outcome of autologous HSCT in adults with high-risk acute lymphoblastic leukemia.
Blood
2009 : Vol. 114, nr 22, abstr. 2321
51st ASH Annual Meeting, New Orleans, USA, [5-8 December 2009].
SZZ
SIF
48/115
Anetta Undas, Konstanty Szułdrzynski, Kathleen E. Brummel-Ziedins, Wiesława Tracz, Krzysztof Zmudka, Kenneth G. Mann.
Systemic blood coagulation activation in acute coronary syndromes.
Blood
2009 : Vol. 113, nr 9, s. 2070-2078, il., bibliogr. 63 poz.
p-ISSN: 0006-4971

AZ
ORG
AIF
IF: 10.555
49/115
François Guilhot, Viviane Dubruille, Aleksander B. Skotnicki, Andrey Hellmann, Jila Shamsazar, Priscille M. Bourquelot, Muhammad Jalaluddin, Martha Li, Elisabetta Abruzzese, Luke Akard.
A Phase II Study of oral panobinostat (LBH589) in accelerated phase (AP) or blast crisis (BC) chronic myeloid leukemia (CML) patients resistant to 2 BCR-ABL tyrosine kinase inhibitors.
Blood
2008 : Vol. 112, nr 11, abstr. 4263
51st ASH Annual Meeting and Exposition, New Orlean, December 5-8, 2009.
SZZ
SIF
50/115
Jerzy Holowiecki, Sebastian Grosicki, Slawomira Kyrcz-Krzemien, Kazimierz Kuliczkowski, Aleksander B. Skotnicki, Andrzej Hellmann, Tadeusz Robak, Kazimierz Sulek, Anna Dmoszynska, Janusz Kloczko, Wieslaw Wiktor Jedrzejczak, Barbara Zdziarska, Krzysztof Warzocha, Krystyna Zawilska, Marek Kielbinski, Beata Piatkowska-Jakubas, Agnieszka Wierzbowska, Olga Haus, Beata Stella-Holowiecka, Malgorzata Krawczyk-Kulis, Malgorzata Wach, Anna Ejduk.
Addition of cladribine to the standard daunorubicine - cytarabine (DA 3+7) remission induction protocol (DAC) contrary to adjunct of fludarabine (DAF) improves the overall survival in untreated adults with acute myeloid leukemia aged up to 60 y : a multicenter, randomized, phase III PALG AML 1/2004 DAF/DAC/DA Study in 673 patients.
Blood
2008 : Vol. 112, nr 11, abstr. 133
51st ASH Annual Meeting and Exposition, New Orlean, December 5-8, 2009.
SZZ
SIF
51/115
Jerzy Z. Blonski, Tadeusz Robak, Jacek Trelinski, Krzysztof Chojnowski, Krzysztof Warzocha, Ilona Seferynska, Lech Konopka, Bernadetta Ceglarek, Malgorzata Calbecka, Aleksandra Kostyra, Beata Stella-Holowiecka, Janusz Kloczko, Anna Dmoszynska, Malgorzata Kowal, Krzysztof Lewandowski, Jadwiga Dwilewicz-Trojaczek, Elzbieta Wiater, Kazimierz Kuliczkowski, Stanislaw Potoczek, Andrzej Hellmann, Andrzej Mital, Aleksander B. Skotnicki, Wieslaw Nowak, Kazimierz Sulek, Andrzej Zdunczyk, Krystyna Zawilska.
Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with cladribine.
Blood
2008 : Vol. 112, nr 11, abstr. 4179
51st ASH Annual Meeting and Exposition, New Orlean, December 5-8, 2009.
SZZ
SIF
52/115
Kajetana Foryciarz, Mathieu Molimard, Francois-Xavier Mahon, Izabela Florek, Tomasz Sacha, Marcin Sobocinski, Aleksander B. Skotnicki.
Imatinib trough plasma concentration and its correlation with clinical response in chronic phase and accelerated phase of CML.
Blood
2008 : Vol. 112, nr 11, abstr. 4269
51st ASH Annual Meeting and Exposition, New Orlean, December 5-8, 2009.
SZZ
SIF
53/115
Barbara Nasilowska-Adamska, Agnieszka Tomaszewska, Richard M. Szydlo, Piotr Rzepecki, Anna Czyz, Joanna Manko, Miroslaw Markiewicz, Tigran Torosian, Maria Bieniaszewska, Beata Piatkowska-Jakubas, Agnieszka Wierzbowska, Dorota Duda, Andrzej Szczepinski, Andrzej Lange, Tadeusz Robak, Aleksander Skotnicki, Andrzej Hellman, Wieslaw W. Jedrzejczak, Jerzy Holowiecki, Anna Dmoszynska, Mieczyslaw Komarnicki, Krzysztof Warzocha, Bozena Marianska.
Palifermin does not influence the incidence and severity of GvHD nor long-term survival of patients with hematological diseases undergoing HSCT.
Blood
2008 : Vol. 112, nr 11, abstr. 4301
51st ASH Annual Meeting and Exposition, New Orlean, December 5-8, 2009.
SZZ
SIF
54/115
Tadeusz Robak, Jerzy Z. Blonski, Krzysztof Jamroziak, Joanna Gora-Tybor, Beata Stella-Holowiecka, Lech Konopka, Bernadetta Ceglarek, Krzysztof Warzocha, Ilona Seferynska, Janusz Kloczko, Jaroslaw Piszcz, Malgorzata Calbecka, Aleksandra Kostyra, Jadwiga Dwilewicz-Trojaczek, Elzbieta Wiater, Anna Dmoszynska, Malgorzata Kowal, Krystyna Zawilska, Alina Grzywacz, Andrzej Hellmann, Andrzej Mital, Andrzej Zdunczyk, Jacek Dybowicz, Kazimierz Kuliczkowski, Stanislaw Potoczek, Aleksander Skotnicki, Maria Nowakowska-Domagala, Krzysztof Lewandowski, Kazimierz Sulek.
Randomized comparison of cladribine plus Ccyclophosphamide with fludarabine plus cyclophosphamde in untreated patients with chronic lymphocytic leukemia : report of the Polish Adult Leukemia Group (PALG-CLL3).
Blood
2008 : Vol. 112, nr 11, abstr. 2103
51st ASH Annual Meeting and Exposition, New Orlean, December 5-8, 2009.
SZZ
SIF
55/115
Marta Antonina Libura, Beata Piatkowska-Jakubas, Olga Haus, Izabela Florek, Bozena Jazwiec, Krystyna Soszynska, Zoriana Salamanchuk, Malgorzata Jakobczyk, Szymon Fornagiel, Tomasz Sacha, Marek Kielbinski, Kazimierz Kuliczkowski, Ewa Duszenko, Anna Jaskowiec, Barbara Mucha, Katarzyna Skonieczna, Aleksander Skotnicki.
Significance of BAALC, MN1, ERG, CEBPa gene expression as new prognostic factors, in the context of other molecular markers in intermediate risk AML group according to cytogenetics, including patients younger than 60 years.
Blood
2008 : Vol. 112, nr 11, abstr. 4855
51st ASH Annual Meeting and Exposition, New Orlean, December 5-8, 2009.
SZZ
SIF
56/115
Wojciech Jurczak, Agnieszka Giza, Dorota Krochmalczyk, Dagmara Zimowska-Curylo, Marcin Sobocinski, Beata Stella-Holowiecka, Aleksandra Holowiecka-Goral, Piotr Boguradzki, Elzbieta Kisiel, Grzegorz Mazur, Tomasz Wrobel, Wanda Knopińska-Posłuszny, Ewa Kalinka-Warzocha, Aleksander B. Skotnicki.
Survival benefit of post induction consolidation therapy in MCL (Mantle Cell Lymphoma) : a Polish Lymphoma Research Group (PLRG) retrospective multicenter analysis.
Blood
2008 : Vol. 112, nr 11, abstr. 4936
51st ASH Annual Meeting and Exposition, New Orlean, December 5-8, 2009.
SZZ
SIF
57/115
Jerzy Holowiecki, Sebastian Grosicki, Slawomira Kyrcz-Krzemien, Kazimierz Kuliczkowski, Marek Kielbinski, Aleksander B. Skotnicki, Beata Piatkowska-Jakubas, Marek Seweryn, Beata Stella-Holowiecka, Maria Sadus-Wojciechowska.
The reduction of leukemic blasts in bone marrow aspirate on day 6 of remission induction treatment is predictive for complete remission rate and survival in adult acute myeloid leukemia : the results of multicenter, prospective Polish Adult Leukemia Group Study.
Blood
2008 : Vol. 112, nr 11, abstr. 1950
51st ASH Annual Meeting and Exposition, New Orlean, December 5-8, 2009.
SZZ
SIF
58/115
Anetta Undas, Kathleen E. Brummel-Ziedins, Kenneth G. Mann.
Antithrombotic properties of aspirin and resistance to aspirin : beyond strictly antiplatelet actions.
Blood
2007 : Vol. 109, nr 6, s. 2285-2292, il., bibliogr. 102 poz., abstr.
p-ISSN: 0006-4971

AZ
POG
AIF
IF: 10.896
Adres url:
59/115
Tadeusz Robak, Krzysztof Jamroziak, Joanna Gora-Tybor, Jerzy Z. Blonski, Marek Kasznicki, Jadwiga Dwilewicz-Trojaczek, Elzbieta Wiater, Andrzej Zdunczyk, Jacek Dybowicz, Anna Dmoszynska, Maria Wojtaszko, Barbara Zdziarska, Malgorzata Calbecka, Aleksandra Kostyra, Andrzej Hellmann, Krzysztof Lewandowski, Beata Stella-Holowiecka, Kazimierz Sulek, Krzysztof Gawronski, Aleksander B. Skotnicki, Wieslaw Nowak, Krystyna Zawilska, Lucyna Molendowicz-Portala, Janusz Kloczko, Jaroslaw Sokolowski, Krzysztof Warzocha, Ilona Seferynska, Bernardeta Ceglarek, Lech Konopka.
Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia : final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial.
Blood
2007 : Vol. 109, nr 9, s. 3672-3675, il., bibliogr., abstr.
p-ISSN: 0006-4971

AZ
ORG
AIF
IF: 10.896
60/115
Hagop Kantarjian, Ricardo Pasquini, Nelson Hamerschlak, Philippe Rousselot, Jerzy Holowiecki, Saengsuree Jootar, Tadeusz Robak, Nina Khoroshko, Tamas Masszi, Aleksander Skotnicki, Andrzej Hellman, Andrey Zaritsky, Anatoly Golenkov, Jerald Radich, Timothy Hughes, Athena Countouriotis, Neil Shah.
Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib : a randomized phase 2 trial.
Blood
2007 : Vol. 109, nr 12, s. 5143-5150, il., bibliogr. 26 poz., abstr.
p-ISSN: 0006-4971

AZ
ORG
AIF
IF: 10.896
Adres url:
61/115
Wojciech Jurczak, A. Giza, M[arta] Szostek, A[licja] Hubalewska-Dydejczyk, A[nna] Sowa-Staszczak, W[anda] Knopinska-Posluszny, A. Hellmann, B. Zdziarska, T. Wrobel, S. Krycz-Krzemien, L. Poplawska, I. Federowicz, Jan Walewski, Aleksander Skotnicki.
99Y-Zevalin (99Y-Ibritumomab Tiuxetan) radioimmunotherapy (RIT) consolidation of FCM induction chemoterapy in mantle cell lymphoma (MCL) patients : results from PLRG upon completed enrollment.
Blood
2006 : Vol. 108, nr 11 Part 1, s. 777a, abstr. 2747
American Society of Hematology Forty-eight annual meeting, Orlando, Florida, December 9-12, 2006.
SZZ
SIF
62/115
Peter Hillmen, Aleksander Skotnicki, Tadeusz Robak, Branimir Jaksic, Cynthia Sirard, Jiri Mayer.
Alemtuzumab (CAMPATH, MABCAMPATH) has superior progression free survival (PFS) vs Chlorambucil as front -line therapy for patients with progressive B-cell chronic lymphocytic leukemia (BCLL).
Blood
2006 : Vol. 108, nr 11 Part 1, s. 93a, abstr. 301
American Society of Hematology Forty-eight annual meeting, Orlando, Florida, December 9-12, 2006.
SZZ
SIF
63/115
D.E. Cramer, D.J. Allendorf, J[arosław] T. Baran, R. Hansen, J. Marroquin, B. Li, J[anina] Ratajczak, M[ariusz] Z. Ratajczak, J. Yan.
β-glucan enhances complement-mediated hematopoietic recovery after bone marrow injury.
Blood
2006 : Vol. 107, nr 2, s. 835-840, il., bibliogr. 31 poz.
AZ
ORG
AIF
IF: 10.370
Adres url:
64/115
Tadeusz Robak, Jerzy Z. Blonski, Joanna Gora-Tybor, Krzysztof Jamroziak, Jadwiga Dwilewicz-Trojaczek, Agnieszka Tomaszewska, Lech Konopka, Bernadetta Ceglarek, Anna Dmoszynska, Malgorzata Kowal, Janusz Kloczko, Beata Stella-Holowiecka, Kazimierz Sulek, Malgorzata Calbecka, Krystyna Zawilska, Kazimierz Kuliczkowski, Aleksander B[artłomiej] Skotnicki, Krzysztof Warzocha, Marek Kasznicki, The Polish Leukemia Group (PALG CLL2).
Cladribine alone and in combination with cyclophosphamide or cyclophosphamide plus mitoxantrone in the treatment of progressive chronic lymphocytic leukemia : report of prospective, multicenter, randomized trial of the Polish Adult Leukemia Group (PALG CLL2).
Blood
2006 : Vol. 108, nr 2, s. 473-479, il., bibliogr., abstr.
AZ
ORG
AIF
IF: 10.370
Adres url:
65/115
Tadeusz Robak, Krzysztof Jamroziak, Joanna Gora-Tybor, Jerzy Z. Blonski, Marek Kasznicki, Jadwiga Dwilewicz-Trojaczek, Anna Dmoszynska, Maria Wojtaszko, Barbara Zdziarska, Malgorzata Calbecka, Andrzej Hellmann, Beata Stella-Holowiecka, Kazimierz Sulek, Aleksander B. Skotnicki, Krystyna Zawilska, Janusz Kloczko, Ilona Seferynska, Lech Konopka, Jaroslaw Piszcz, Bernadetta Ceglarek, Krzysztof Lewandowski, Krzysztof Gawronski, Aleksandra Kostyra, Wieslaw Nowak, Elzbieta Wiater, Jacek Dybowicz, Maria Wojtaszko, Lucyna Molendowicz-Portala.
Cladribine in weekly versus daily schedule for untreated active hairy cell leukemia : final report of Polish Adult Leukemia Group (PALG) Prospective, Randomized, Multicenter Trial.
Blood
2006 : Vol. 108, nr 11 Part 1, s. 704a, abstr. 2485
American Society of Hematology Forty-eight annual meeting, Orlando, Florida, December 9-12, 2006.
SZZ
SIF
66/115
Anna Zebzda, Artur Jurczyszyn, Wojciech Czogala, Ewa Lesko, Jolanta Gozdzik, Aleksander B. Skotnicki, Marcin Majka.
Comparison of myeloma cells killing efficiency by geldanamycin and its analogs.
Blood
2006 : Vol. 108, nr 11 Part 2, s. 345b, abstr. 5027
American Society of Hematology Forty-eight annual meeting, Orlando, Florida, December 9-12, 2006.
SZZ
SIF
67/115
Jerzy Holowiecki, Sebastian Grosicki, Andrzej Hellmann, Aleksander Skotnicki, Tadeusz Robak, Wieslaw W. Jedrzejczak, Lech Konopka, Kazimierz Kuliczkowski, Slawomira Kyrcz-Krzemien, Beata Stella-Holowiecka.
Improved survival in acute myeloid leukaemia patients aged over 40 given cladribine in combination with standard remission induction (DA 3+7) and consolidation treatment (HD AraC).
Blood
2006 : Vol. 108, nr 11 Part 1, s. 566a, abstr. 2003
American Society of Hematology Forty-eight annual meeting, Orlando, Florida, December 9-12, 2006.
SZZ
SIF
68/115
Tadeusz Robak, Anna Dmoszynska, Raouf Fetni, Ying Wang, Malika Belkacz, Cynthia Sirard, Mark Goldberg, Aleksander Skotnicki, Jiri Mayer, Peter Hillmen.
Incidence of genomic aberrations and associated efficacy from a phase III study comparing alemtuzumab (CAMPATH, MABCAMPATH) vs chlorambucil as first line therapy for B-cell chronic lymphocytic leukemia (BCLL).
Blood
2006 : Vol. 108, nr 11 Part 1, s. 593a, abstr. 2093
American Society of Hematology Forty-eight annual meeting, Orlando, Florida, December 9-12, 2006.
SZZ
SIF
69/115
Oktawiusz Wiecha, Witold Miezynski, Leszek Wojakowski, Anna Zebzda, Anna Wedrychowicz, Jolanta Gozdzik, Marcin Majka.
New GvHD mouse model for assessing both acute and chronic phase of the disease.
Blood
2006 : Vol. 108, nr 11 Part 2, s. 382B-382B, abstr. 5166.
American Society of Hematology Forty-eight annual meeting, Orlando, Florida, December 9-12, 2006.
SZZ
SIF
70/115
Tadeusz Robak, Jerzy Z. Blonski, Joanna Gora-Tybor, Krzysztof Jamroziak, Bernadetta Ceglarek, Lech Konopka, Malgorzata Calbecka, Aleksandra Kostyra, Beata Stella-Holowiecka, Janusz Kloczko, Krzysztof Warzocha, Ilona Seferynska, Anna Dmoszynska, Malgorzata Kowal, Krzysztof Lewandowski, Jadwiga Dwilewicz-Trojaczek, Elzbieta Wiater, Stanislaw Potoczek, Andrzej Hellmann, Aleksander Skotnicki, Kazimierz Sulek, Jacek Dybowicz, Krystyna Zawilska.
Randomized comparison of cladribine Plus cyclophsophamide with fludarabine plus cyclophosamide in progressive chronic lymphocytic leukemia : an updated report of prospective PALG-CLL3 Study.
Blood
2006 : Vol. 108, nr 11 Part 1, s. 800a, abstr. 2826
American Society of Hematology Forty-eight annual meeting, Orlando, Florida, December 9-12, 2006.
SZZ
SIF
71/115
B[arbara] Nasilowska-Adamska, P. Rzepecki, J. Manko, J. Czyz, M. Markiewicz, I. Fedorowicz, A. Tomaszewska, B[eata] Piatkowska-Jakubas, A[gata] Wrzesien-Kus, M. Bieniaszewska, D. Duda, K. Halaburda, A. Szczepinski, A. Lange, A. Hellmann, T. Robak, A[leksander] Skotnicki, Wieslaw W. Jedrzejczak, J. Walewski, J[erzy] Holowiecki, M. Komarnicki, A. Dmoszynska, K. Warzocha, B. Marianska.
The significance of palifermin (Kepivance) in reduction of oral mucositis (OM) incidence and acute graft versus host disease (aGvHD) in patients with hematological diseases undergoing HSCT.
Blood
2006 : Vol. 108, nr 11 Part 1, s. 840a, abstr. 2965
American Society of Hematology Forty-eight annual meeting, Orlando, Florida, December 9-12, 2006.
SZZ
SIF
72/115
Marcin Majka, Artur Jurczyszyn, Anna Zebzda, Wojciech Czogala, Ewa Lesko, Zbigniew Rudzki, Jolanta Gozdzik, Teresa Wolska-Smolen, Aleksander B. Skotnicki, Mariusz Z. Ratajczak.
C-met receptor as a potential target for the treatment of patients with multiple myeloma.
Blood
2005 : Vol. 106, nr 11 Part 1, s. 948a, abstr. 3395
American Society of Hematology Forty-seven Annual Meeting, Atlanta, Georgia, December 10-13, 2005.
SZZ
SIF
73/115
Malgorzata Kowal, Wieslaw Nowak, Aleksandra Nowaczynska, Anna Dmoszynska, Aleksander Skotnicki.
Combined schedule of Fludarabine and Alemtuzumab followed by maintenance with low-dose Alemtuzumab is effective for patients with progressive B-Cell chronic lymphocytic leukemia.
Blood
2005 : Vol. 106, nr 11 Part 2, s. 343b, abstr. 5048
American Society of Hematology Forty-seven Annual Meeting, Atlanta, Georgia, December 10-13, 2005.
SZZ
SIF
74/115
W[ojciech] Jurczak, A. Giza, D[orota] Krochmalczyk, J[oanna] Wegrzyn, A[licja] Hubalewska-Hola, A[nna] Sowa-Staszczak, W[anda] Knopinska-Posluszny, B. Zdziarska, S. Krycz-Krzemien, P. Boguradzki, L. Poplawska, A[leksander] Skotnicki.
Consolidation of chemotherapy response in mantle cell lymphoma (MCL) patients with 90Y-Ibritumomab Tiuxetan (90Y-Zevalin) radioimmunotherapy (RIT).
Blood
2005 : Vol. 106, nr 11 Part 1, s. 690a, abstr. 2453
American Society of Hematology Forty-seven Annual Meeting, Atlanta, Georgia, December 10-13, 2005.
SZZ
SIF
75/115
Piotr Centkowski, Lidia Brydak, Magdalena Machala, Ewa Kalinka, Maria Blasinska-Morawiec, Joanna Wegrzyn, Aleksander Skotnicki, Irena Federowicz, Jan Walewski, Dariusz Wolowiec, Joanna Sawczuk-Chabin, Przemyslaw Bilinski, Krzysztof Warzocha.
Good but variable humoral response to trivalent influenza vaccination in patients wityh Non-Hodgkin's Lymphoma - two seasions experience.
Blood
2005 : Vol. 106, nr 11 Part 2, s. 251b, abstr. 4685
American Society of Hematology Forty-seven Annual Meeting, Atlanta, Georgia, December 10-13, 2005.
SZZ
SIF
76/115
Paula M. Chilton, Francine Rezzoug, Mariusz Z. Ratajczak, Isabelle Fugier-Vivier, Janina Ratajczak, Magda Kucia, Yiming Huang, Michael K. Tanner, Suzanne T. Ildstad.
Hematopoietic stem cells from NOD mice exhibit autonomous behavior and a competitive advantage in allogeneic recipients.
Blood
2005 : Vol. 105, nr 5, s. 2189-2197, il., bibliogr. 57 poz.
AZ
ORG
AIF
IF: 10.131
Adres url:
77/115
Marcin Wysoczynski, Ryan Reca, Janina Ratajczak, Magda Kucia, Neeta Shirvaikar, Marek Honczarenko, Michael Mills, Jens Wenzeck, Anna Janowska-Wieczorek, Mariusz Z. Ratajczak.
Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem/progenitor cells to an SDF-1 gradient.
Blood
2005 : Vol. 105, nr 1, s. 40-48, il., bibliogr., abstr.
AZ
ORG
AIF
IF: 10.131
Adres url:
78/115
Marek Hus, Norbert Grzasko, Dariusz Jawniak, Marta Szostek, Anna Dmoszynska.
Lovastatin as Salvage Immunomodulatory Therapy in Patients with Refractory and Relapsed Multipla Myeloma.
Blood
2005 : Vol. 106, nr 11 Part 1, s. 1567
American Society of Hematology Forty-seven Annual Meeting, Atlanta, Georgia, December 10-13, 2005.
SZZ
SIF
79/115
W[ojciech] Jurczak, M[arta] Szostek, A. Giza, Z[bigniew] Rudzki, A[leksander] Skotnicki.
Manageable and transient hematologic toxicity associated with 90Y-Ibritumomab Tiuxetan (90Y-Zevalin) consolidation of FCM chemotherapy in mantle cell lymphoma (MCL) patients.
Blood
2005 : Vol. 106, nr 11 Part 2, s. 278b, abstr. 4793
American Society of Hematology Forty-seven Annual Meeting, Atlanta, Georgia, December 10-13, 2005.
SZZ
SIF
80/115
Jerzy Holowiecki, Sebastian Grosicki, Slawomira Kyrcz-Krzemien, Janusz Kloczko, Kazimierz Sulek, Andrzej Hellmann, Aleksander Skotnicki, Kazimierz Kuliczkowski, Krystyna Zawilska, Tadeusz Robak, Anna Dmoszynska, Krzysztof Warzocha.
Prospective, randomized multicenter phase III, Polish Adult Leukemia Group (PALG) study comparing DAF (DNR+AraC+Fludarabine), DAC (DNR+AraC+Cladribine), and standard DA regimen in induction of untreated acute myeloid leukaemia patients - first report.
Blood
2005 : Vol. 106, nr 11 Part 2, s. 233b, abstr. 4616
American Society of Hematology Forty-seven Annual Meeting, Atlanta, Georgia, December 10-13, 2005.
SZZ
SIF
81/115
Jerzy Holowiecki, Sebastian Grosicki, Tadeusz Robak, Slawomira Krzemien, Sebastian Giebel, Andrzej Hellmann, Aleksander Skotnicki, Wieslaw W. Jedrzejczak, Lech Konopka, Kazimierz Kuliczkowski, Barbara Zdziarska, Anna Dmoszynska.
Addition of cladribine to the standard AML treatment improves long-term outcome in high tumor burden and older than 40 years acute myeloid leukemia group (PALG 1999 DAC vs. DA Study).
Blood
2004 : Vol. 104, nr 11 Part 1, s. 497a, abstr. 1795
American Society of Hematology Forty-six annual meeting, San Diego, California, December 4-7, 2004.
SZZ
SIF
82/115
Jerzy Holowiecki, Sebastian Grosicki, Andrzej Hellmann, Aleksander Skotnicki, Wieslaw W. Jedrzejczak, Anna Dmoszynska, Bozena Marianska, Tadeusz Robak, Sebastian Giebel, Jerzy Wojnar, Malgorzata Krawczyk-Kulis, Maria Wojciechowska.
Addition of purine analogues to induction/consolidation regimen does not impair peripheral blood stem cell mobilization and bone marrow harvest for autotransplantation in acute myeloid leukemia.
Blood
2004 : Vol. 104, nr 11 Part 2, s. 384b, abstr. 5198
American Society of Hematology Forty-six annual meeting, San Diego, California, December 4-7, 2004.
SZZ
SIF
83/115
Tadeusz Robak, Jerzy Z. Blonski, Joanna Gora-Tybor, Marek Kasznicki, Jadwiga Dwilewicz-Trojaczek, Agnieszka Tomaszewska, Lech Konopka, Bernadeta Ceglarek, Janusz Kloczko, Jaroslaw Sokolowski, Anna Dmoszynska, Malgorzata Kowal, Krystyna Zawilska, Beata Stella-Holowiecka, Kazimierz Sulek, Kazimierz Kuliczkowski, Krzysztof Warzocha, Malgorzata Calbecka, Aleksander Skotnicki.
Cladribine alone or in combination with cyclophosphamide or cyclophosphamide and mitoxantrone as first line treatment in chronic lymphocytic leukemia : an early report of prospective randomized study.
Blood
2004 : Vol. 104, nr 11 Part 1, s. 100a, abstr. 337
American Society of Hematology Forty-six annual meeting, San Diego, California, December 4-7, 2004.
SZZ
SIF
84/115
Jerzy Holowiecki, Sebastian Grosicki, Slawomira Krzemien, Aleksander Skotnicki, Krzysztof Warzocha, Barbara Zdziarska, Beata Stella-Holowiecka, Malgorzata Krawczyk-Kulis, Malgorzata Kopera, Maria Wojciechowska.
Daunorubicin, cytarabine and fludarabine (DAF) for the treatment of relapsed-refractory acute myeloid leukemia. Phase II study by the Polish Adult Leukemia Group (PALG).
Blood
2004 : Vol. 104, nr 11 Part 2, s. 210b, abstr. 4507
American Society of Hematology Forty-six annual meeting, San Diego, California, December 4-7, 2004.
SZZ
SIF
85/115
Piotr Centkowski, Lidia Brydak, Magdalena Machala, Ewa Kalinka, Maria Blasinska-Morawiec, Joanna Wegrzyn, Aleksander Skotnicki, Irena Federowicz, Jan Walewski, Ilona Seferynska, Przemyslaw Bilinski, Krzysztof Warzocha.
Evaluation of humoral response to trivalent influenza vaccination in patients with non-Hodgkin's lymphoma previously treated or untreated with chemotherapy.
Blood
2004 : Vol. 104, nr 11 Part 2, s. 218b, abstr. 4537
American Society of Hematology Forty-six annual meeting, San Diego, California, December 4-7, 2004.
SZZ
SIF
86/115
Wojciech Jurczak, Marta Szostek, Zbigniew Rudzki, Dorota Krochmalczyk, Joanna Wegrzyn, Jaroslaw Czyz, Aleksander B. Skotnicki.
Impaired clonogenic capacity contributes to bone marrow hypoplasia and late hematological recovery after Zevalin in the low-grade NHL patients.
Blood
2004 : Vol. 104, nr 11 Part 2, s. 336b, abstr. 4610
American Society of Hematology Forty-six annual meeting, San Diego, California, December 4-7, 2004.
SZZ
SIF
87/115
Janina Ratajczak, Ryan Reca, Magdalena Kucia, Marcin Majka, D.J. Allendorf, Jarek T. Baran, Anna Janowska-Wieczorek, R.A. Wetsel, G.D. Ross, Mariusz Z. Ratajczak.
Mobilization studies in mice deficient in either C3 or C3a receptor (C3aR) reveal a novel role for complement in retention of hematopoietic stem/progenitor cells in bone marrow.
Blood
2004 : Vol. 103, nr 6, s. 2071-2078, il., bibliogr., abstr.
AZ
ORG
AIF
IF: 9.782
Adres url:
88/115
Peter Hillmen, Aleksander B. Skotnicki, Tadeusz Robak, Jiri Mayer, Branimir Jaksic, Vojo Vukovic, Steven Weitman.
Preliminary safety and efficacy report of a randomized trial of alemtuzumab vs chlorambucil as front-line therapy in 297 patients with progressive B-Cell chronic lymphocytic leukemia.
Blood
2004 : Vol. 104, nr 11 Part 1, s. 687a, abstr. 2505
American Society of Hematology Forty-six annual meeting, San Diego, California, December 4-7, 2004.
SZZ
SIF
89/115
Tadeusz Robak, Marek Kasznicki, Joanna Gora-Tybor, Jadwiga Dwilewicz-Trojaczek, Anna Dmoszynska, Maria Wojtaszko, Barbara Zdziarska, Malgorzata Calbecka, Andrzej Hellmann, Beata Stella-Holowiecka, Kazimierz Sulek, Aleksander Skotnicki, Krystyna Zawilska, Janusz Kloczko, Krzysztof Warzocha, Lech Konopka.
Randomized comparison of weekly administration and daily courses of cladribine in patients with hairy cell leukemia - updated results.
Blood
2004 : Vol. 104, nr 11 Part 1, s. 948a, abstr. 3478
American Society of Hematology Forty-six annual meeting, San Diego, California, December 4-7, 2004.
SZZ
SIF
90/115
Susan Branford, Zbigniew Rudzki, Ian Parkinson, Andrew Grigg, Kerry Taylor, John F. Seymour, Simon Durrant, Peter Browett, Anthony P. Schwarer, Chris Arthur, John Catalano, Michael F. Leahy, Robin Filshie, Kenneth Bradstock, Richard Hermann, David Joske, Kevin Lynch, Tim Hughes.
Real-time quantitative PCR analysis can be used as a primary screen to identify patients with CML treated with imatinib who have BCR-ABL kinase domain mutations.
Blood
2004 : Vol. 103, nr 9, s. 2926-2932, il., bibliogr. 38 poz.
AZ
ORG
AIF
IF: 9.782
Adres url:
91/115
Tadeusz Robak, Jerzy Z. Blonski, Marek Kasznicki, Joanna Gora-Tybor, Anna Dmoszynska, Maria Wojtaszko, Aleksander Skotnicki, Wieslaw Nowak, Andrzej Hellmann, Krzysztof Lewandowski, Barbara Zdziarska, Lech Konopka, Bernadeta Ceglarek, Jadwiga Dwilewicz-Trojaczek, Piotr Boguradzki, Kazimierz Kuliczkowski, Kazimierz Sulek, Krzysztof Warzocha.
The effect of subsequent therapies in the patients with chronic lymphocytic leukemia previously treated with cladribine and prednisone or chlorambucil and prednisone in randomized studies.
Blood
2004 : Vol. 104, nr 11 Part 2, s. 287b, abstr. 4819
American Society of Hematology Forty-six annual meeting, San Diego, California, December 4-7, 2004.
SZZ
SIF
92/115
Sebastian Giebel, Jerzy Holowiecki, Malgorzata Krawczyk-Kulis, Slawomira Kyrcz-Krzemien, Andrzej Hellmann, Anna Dmoszynska, Monika Paluszewska, Tadeusz Robak, Lech Konopka, Ilona Seferynska, Aleksander Skotnicki, Wojciech Baran, Maria Adamczyk-Cioch, Agata Wrzesien-Kus, Krystyna Jagoda.
Time-sequenced G-CSF (Lenograstim) for the treatment of adult acute lymphoblastic leukemia - seven year follow-up of the Polish Adult Leukemia Group 4-96 Study.
Blood
2004 : Vol. 104, nr 11 Part 1, s. 747a, abstr. 2733
American Society of Hematology Forty-six annual meeting, San Diego, California, December 4-7, 2004.
SZZ
SIF
93/115
Jan Styczynski, Mariusz Wysocki, Andrzej Kurylak, Krzysztof Czyzewski, Walentyna Balwierz, Edyta Juraszewska, Michal Matysiak, Iwona Malinowska, Elzbieta Stanczak, Jacek Wachowiak, Benigna Konatkowska, Danuta Sonta-Jakimczyk, Tomasz Szczepanski, Anna Balcerska, Anna Ploszynska, Jerzy Kowalczyk, Jolanta Stefaniak, Maryna Krawczuk-Rybak, Marta Kuzmicz, Maria Wieczorek, Igor Olejnik, Wanda Badowska, Roma Rokicka-Milewska, Alicja Chybicka.
Bcl-2, but not p53 expression correlates with lack of early response in childhood ALL; bcl-2, p53, MRP1 and LRP expression have no impact on drug resistance in childhood AML.
Blood
2003 : Vol. 102, nr 11 Part 2, s. 198b, abstr. 4509
American Society of Hematology. Forty-fith Annual Meeting Program and Abstracts, San Diego, California, December 6-9, 2003.
SZZ
SIF
94/115
Ryan Reca, Dimitrios Mastellos, Marcin Majka, Leah Marquez, Janina Ratajczak, Silvia Franchini, Aleksandra Glodek, Marek Honczarenko, Lynn A. Spruce, Anna Janowska-Wieczorek, John D. Lambris, Mariusz Z. Ratajczak.
Functional receptor for C3a anaphylatoxin in expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1.
Blood
2003 : Vol. 101, nr 10, s. 3784-3793, il., bibliogr. 60 poz.
AZ
ORG
AIF
IF: 10.120
Adres url:
95/115
Beata Piatkowska-Jakubas, Anna Wojas-Pelc, Patrycja Mensach, Dorota Hawrylecka, Janusz Krawczyk, Aleksander B[artłomiej] Skotnicki.
Psoralen and ultraviolet A irradiation as adjuvant treatment of chronic extensine graft versus host disease (GVHD) in adults.
Blood
2003 : Vol. 102, nr 11 Part 2, s. 456b, abstr. 5549
American Society of Hematology. Forty-fith Annual Meeting Program and Abstracts, San Diego, December 6-9, 2003.
SZZ
SIF
Adres url:
96/115
Milosz Jankowski, Ingrid Vreys, Christine Wittevrongel, Doris Boon, Jos Vermylen, Marc Hoylaerts, Jef Arnout.
Thrombogenicity of β2-glycoprotein I-dependent antiphospholipid antibodies in a photochemically induced thrombosis model in the hamster.
Blood
2003 : Vol. 101, nr 1, s. 157-162, il., bibliogr. 40 poz.
AZ
ORG
AIF
IF: 10.120
Adres url:
97/115
Marek Honczarenko, Yi Le, Aleksandra M. Glodek, Marcin Majka, James J. Campbell, Mariusz Z. Ratajczak, Leslie E. Silberstein.
CCR5-binding chemokines modulate CXCL12 (SDF-1)-induced responses of progenitor B cells in human bone marrow through heterologous desensitization of the CXCR chemokine receptor.
Blood
2002 : Vol. 100, nr 7, s. 2321-2329, il., bibliogr. 39 poz.
AZ
ORG
AIF
IF: 9.631
Adres url:
98/115
J. Libura, J. Drukala, M[arcin] Majka, O. Tomescu, J.M. Navenot, M. Kucia, L[eah] Marquez, S.C. Peiper, F.G. Barr, A[nna] Janowska-Wieczorek, M[ariusz] Z. Ratajczak.
CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion.
Blood
2002 : Vol. 100, nr 7, s. 2597-2606.
AZ
ORG
AIF
IF: 9.631
Adres url:
99/115
Selina M. Luger, Stephen G. O'Brien, Janina Ratajczak, Mariusz Z. Ratajczak, Rosemarie Mick, Edward A. Stadtmauer, Peter C. Nowell, John M. Goldman, Alan M. Gewirtz.
Oligodeoxynucleotide-mediated inhibition of c-myb gene expression in autografted bone marrow : a pilot study.
Blood
2002 : Vol. 99, nr 4, s. 1150-1158, il., bibliogr. 96 poz.
AZ
ORG
AIF
IF: 9.631
Adres url:
100/115
Anetta Undas, Kathleen E. Brummel, Jacek Musiał, Kenneth G. Mann, Andrzej Szczeklik.
Blood coagulation at the site of microvascular injury : effects of low-dose aspirin.
Blood
2001 : Vol. 98, nr 8, s. 2423-2431, bibliogr.
AZ
AIF
IF: 9.273
Adres url:
101/115
Esther Pertussini, Janina Ratajczak, Marcin Majka, David Vaughn, Mariusz Z. Ratajczak, Alan M. Gewirtz.
Investigating the platelet-sparing mechanism of paclitaxel/carboplatin combination chemotherapy.
Blood
2001 : Vol. 97, nr 3, s. 638-644, il., bibliogr. 24 poz.
AZ
AIF
IF: 9.273
102/115
M[arcin] Majka, A[nna] Janowska-Wieczorek, J. Ratajczak, K. Ehrenman, Z. Pietrzkowski, M.A. Kowalska, A.M. Gewirtz, S.G. Emerson, Mariusz Z. Ratajczyk.
Numerous growth factors, cytokines and chemokines are secreted by human CD34+ cells, myeloblasts, erythroblasts and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner.
Blood
2001 : Vol. 97, s. 3075-3085.
AZ
AIF
IF: 9.273
103/115
Anna Janowska-Wieczorek, Marcin Majka, Jacek Kijowski, Monika Baj-Krzyworzeka, Ryan Reca, A. Robert Turner, Janina Ratajczak, Steven G. Emerson, M. Anna Kowalska, Mariusz Z. Ratajczak.
Plateled-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engrafment.
Blood
2001 : Vol. 98, nr 10, s. 3143-3149, il., bibliogr. 31 poz.
Autor korespondencyjny: Mariusz Z. Ratajczak.
Anna Janowska-Wieczorek and Marcin Majka contributed equally to this work.

AZ
AIF
IF: 9.273
Adres url:
Streszczenie w PubMed:
DOI:
104/115
Tadeusz Robak, Jerzy Z. Blonski, Marek Kasznicki, Maria Blasińska-Morawiec, Euzebiusz Krykowski, Anna Dmoszyńska, Halina Mrugala-Śpiewak, Aleksander B. Skotnicki, Wieslaw Nowak, Lech Konopka, Bernadeta Ceglarek, Stanislaw Maj, Jadwiga Dwilewicz-Trojaczek, Andrzej Hellmann, Ignacy Urasiński, Barbara Zdziarska, Sabina Kotlarek-Haus, Stanislaw Potoczek, Pawel Grieb.
Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia : report of a prospective, randomized, multicenter trial.
Blood
2000 : Vol. 96, nr 8, s. 2723-2729, il., bibliogr. 38 poz.
AZ
ORG
AIF
IF: 8.977
105/115
A[netta] Undas, E.B. Williams, S. Butenas, T. Orfeo, K.G. Mann.
Homocysteine incorporation into human factor Va and activated protein C resistance.
Blood
2000 : Vol. 96, nr 11, abstr. 3527.
SZZ
SIF
106/115
M. Anna Kowalska, Mariusz Z. Ratajczak, Marcin Majka, Jianguo Jin, Satya Kunapuli, Lawrence Brass, Mortimer Poncz.
Stromal cell-derived factor-1 and macrophage-derived chemokine: 2 chemokines that activate platelets.
Blood
2000 : Vol. 96, nr 1, s. 50-57, il., bibliogr. 45 poz.
AZ
ORG
AIF
IF: 8.977
Adres url:
Streszczenie w PubMed:
107/115
Marcin Majka, Anna Janowska-Wieczorek, Janina Ratajczak, M. Anna Kowalska, Gaston Vilaire, Zhixing K. Pan, Marek Honczarenko, Leah A. Marquez, Mortimer Poncz, Mariusz Z. Ratajczak.
Stromal-derived factor-1 and thrombopoietin regulate distinct aspects of human megakaryopoiesis.
Blood
2000 : Vol. 96, nr 13, s. 4142-4151, il., bibliogr. 62 poz.
AZ
ORG
AIF
IF: 8.977
Adres url:
Streszczenie w PubMed:
108/115
M[aciej] Machaczka, M[ałgorzata] Rucinska, A. Balana-Nowak, A[gnieszka] Zaluska, E[dyta] Zdzilowska, W[ojciech] Jurczak, T[eresa] Wolska-Smolen, J[oanna] Wegrzyn, W[iesław] S. Nowak, A[leksander] B. Skotnicki.
P-Glycoprotein mediated multidrug resistance phenotype in de novo adult acute myelogenous leukemia (AML). (Wielolekowa oporność zależna od glikoproteiny P u chorych z de novo AML).
Blood
1999 : Vol. 94, nr 10 suppl. 1 p. 2 s. 194b, abstr. 4056.
Forty-First Annual Meeting of American Society of Hematology, New Orleans, December 3-7, 1999.
SZZ
SIF
109/115
B[eata] Piątkowska-Jakubas, A. Balana-Nowak, A[leksander] B. Skotnicki, K. Bulinska.
High expression of CD 34 antigen in leukaemic phenotypes in adult patients with de novo all - an unvfavorable prognostic factor.
Blood
1998 : Vol. 92, nr 10 suppl. 1, s. 204b, abstr. 3871
American Society of Hematology. Fortieth Annual Meeting, December 4-8, 1998, Miami Beach, FL.
SZZ
SIF
110/115
T. Robak, M[aria] Błasińska-Morawiec, J.Z. Błoński, A. Hellman, L. Konopka, S. Kotlarek-Haus, J. Hansz, A[nna] Dmoszyńska, J. Dwilewicz-Trojaczek, B. Zdziarska, J[erzy] Hołowiecki, A[leksander] B. Skotnicki.
Long-term follow-up of patients with hairy cell leukemia (HCL) after treatment with 2- chlorodeoxyadenosine (2-CdA) given in 2-hour infusions.
Blood
1998 : Vol. 92, nr 10 suppl. 1, s. 282b, abstr. 4217
American Society of Hematology, Fortieth Annual Meeting, December 4-8,1998, Miami Beatch, Fl.
SZZ
SIF
111/115
T. Robak, M[aria] Błasińska-Morawiec, J.Z. Błoński, E. Krykowski, A[nna] Dmoszyńska, A[leksander] B. Skotnicki, L. Konopka, A. Hellman, J. Dwilewicz-Trojaczek, B. Zdziarska, S. Kotlarek-Haus, S. Maj.
Randomized multicenter study of the effectiveness of 2-chlorodeoxyadenosine with prednisone or chlorambucil with prednisone in previously untreated chronic lymphocytic leukemia (CLL).
Blood
1998 : Vol. 92, nr 10 suppl. 1, s. 490a, abstr. 2021
American Society of Hematology. Fortieth Annual Meeting, December 4-8, 1998, Miami Beach, FL.
SZZ
SIF
112/115
M[aciej] Machaczka, A. Balana-Nowak, M[ałgorzata] Rucińska, W[ojciech] Jurczak, A[leksander] B. Skotnicki.
The clinical significance of P-glycoprotein expression in de novo adult acute myelogenous leukemia (AML).
Blood
1998 : Vol. 92, nr 10 suppl. 1, s. 194b, abstr. 3826
American Society of Hematology, Fortieth Annual Meeting, December 4-8,1998, Miami Beatch, Fl.
SZZ
SIF
113/115
T[omasz] Sacha, J[ózef] Dulak, D[orota] Hawrylecka, J[acek] Musiał, I. Florek, A[ldona] Dembińska-Kieć, A[leksander] B. Skotnicki.
The significance of the breakpoint location within M-BCR - the type of chimeric mRNA in chronic myelogenus leukemia and the Sokal prognostic index.
Blood
1998 : Vol. 92, nr 10 suppl. 1, abstr. 4068
American Society of Hematology. Fortieth Annual Meeting, December 4-8, 1998, Miami Beach, FL.
SZZ
SIF
114/115
A[ndrzej] Szczeklik, M[arek] Krzanowski, P. Góra, J[adwiga] Radwan.
Antiplatelet drugs and generation of thrombin in clotting blood.
Blood
1992 : Vol. 80, nr 8, s. 2006-2011, il., bibliogr. 26 poz.
p-ISSN: 0006-4971

AZ
ORG
IF: 8.061
115/115
Seymour J. Klebanoff, Slawomir Olszowski, Wesley C. Van Voorhis, Jeffrey A. Ledbetter, Ann M Waltersdorph, Kristie G. Schlechte.
Effects of γ interferon on human neutrophilis: protection from deterioration on storage.
Blood
1992 : Vol. 80, nr 1, s. 225-234, il., bibliogr. 52 poz.
p-ISSN: 0006-4971

AZ
ORG
IF: 8.061
  Wyświetl ponownie stosując format:
Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ